Fortis Healthcare Ltd

Fortis Healthcare Limited will hold a board meeting on Thursday, August 06, 2026, to consider and approve the unaudited financial results (standalone & consolidated) for the quarter ended June 30, 2026, according to a regulatory filing. The company also announced that the trading window for dealing in securities will remain closed until August 08, 2026, following a previous announcement on June 24, 2026.

Fortis Healthcare has fixed 24 July 2026 as record date for payment of final dividend for FY 2026.

Fortis Healthcare announced that the Annual General Meeting(AGM) of the company will be held on 11 August 2026.

Fortis Healthcare announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.

Net profit of Fortis Healthcare rose 44.57% to Rs 265.85 crore in the quarter ended March 2026 as against Rs 183.89 crore during the previous quarter ended March 2025. Sales rose 17.81% to Rs 2364.67 crore in the quarter ended March 2026 as against Rs 2007.20 crore during the previous quarter ended March 2025. For the full year,net profit rose 34.56% to Rs 1041.78 crore in the year ended March 2026 as against Rs 774.21 crore during the previous year ended March 2025. Sales rose 17.28% to Rs 9127.84 crore in the year ended March 2026 as against Rs 7782.75 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2364.672007.20 18 9127.847782.75 17 OPM %22.5121.70 -22.8420.40 - PBDT458.66392.35 17 1837.521481.99 24 PBT336.69290.12 16 1388.091096.38 27 NP265.85183.89 45 1041.78774.21 35 Powered by Capital Market - Live

Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 22 May 2026.

Net profit of Fortis Healthcare declined 21.85% to Rs 193.73 crore in the quarter ended December 2025 as against Rs 247.90 crore during the previous quarter ended December 2024. Sales rose 17.46% to Rs 2265.01 crore in the quarter ended December 2025 as against Rs 1928.26 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2265.011928.26 17 OPM %22.3219.45 - PBDT431.73352.92 22 PBT311.59255.59 22 NP193.73247.90 -22 Powered by Capital Market - Live

Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live

Fortis Healthcare announced that its wholly owned subsidiary, International Hospital on 19 December 2025 has signed definitive agreements for acquisition of TMI Healthcare (primarily comprises hospital operations) through a share purchase agreement and acquisition of the underlying hospital land and building, and the adjacent land thereto (Proposed Transaction). The acquisition will enable the company to expand, scale up and deliver quality healthcare services to patients in Bengaluru. TMI Healthcare comprises the People Tree Hospital, Yeshwanthpur and two identified facilities (People Tree Hospital, Raghavendra and People Tree Hospital, Meenakshi). As part of the transaction to acquire 100% equity stake in TMI Healthcare; the above identified facilities would be carved out from TMI Healthcare prior to transaction closure. In addition to the acquisition of TMI Healthcare, IHL is also acquiring the underlying land and hospital building and an adjacent land parcel.Powered by Capital Market - Live

Fortis Healthcare on 20 December 2025 announced plans to invest around Rs 840 crore to expand its footprint in Bengaluru, as part of its cluster focused growth strategy in the city. The company said it has signed definitive agreements to acquire the 125 bedded People Tree Hospital in Yeshwanthpur through its wholly owned subsidiary, International Hospital. The composite transaction, including the acquisition of the hospital business, building and land, is valued at Rs 430 crore, including debt. Fortis will also acquire an adjacent land parcel of around 0.8 acres, which will allow the facility to scale up to more than 300 beds. An additional investment of about Rs 410 crore is planned over the next three years to expand bed capacity, upgrade medical equipment and add clinical programmes such as radiation oncology. People Tree Hospital Yeshwanthpur is a NABH accredited multi specialty facility offering services across cardiac sciences, orthopaedics, neurosciences, renal sciences and gastroenterology. Based on current revenues of about Rs 74 crore in FY25, Fortis said it sees scope to improve utilisation, revenues and profitability while executing the expansion. The transaction is expected to be completed by the end of January 2026, subject to customary conditions. With this acquisition, Fortis said its Bengaluru network has the potential to scale up to over 1,500 beds across seven facilities over the next three years, from about 900 beds at present. Fortis Healthcare is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates 33 healthcare facilities (including JVs and O&M facilities) across 11 states. The company's network comprises approximately 5,800 operational beds (including O&M beds) and over 400 diagnostics labs. On a consolidated basis, Fortis Healthcare's net profit rose 82.43% to Rs 321.92 crore while net sales rose 17.25% to Rs 2331.44 crore in Q2 September 2025 over Q2 September 2024. Powered by Capital Market - Live